Suppr超能文献

胃痛之上又添胃痛:药物性胰腺炎

Stomach Pain Upon Stomach Pain: Medication-Induced Pancreatitis.

作者信息

Chambers Ethan K, Stratulat Eugeniu, Judge Gurjeet, Shafique Seaf, Ladel Luisa

机构信息

Internal Medicine, Norwalk Hospital, Norwalk, USA.

出版信息

Cureus. 2023 Feb 27;15(2):e35554. doi: 10.7759/cureus.35554. eCollection 2023 Feb.

Abstract

As a first-line immunosuppressant to maintain remission in Crohn's disease, 6-mercaptopurine (6-MP) has been commonly used. A rare, unpredictable, dose-independent and idiosyncratic reaction to this medication is acute pancreatitis. Unlike other side effects of this drug which have been well characterized and are often dose-dependent, acute pancreatitis is an uncommon adverse effect not frequently encountered in clinical practice. In this case report, we describe a 40-year-old man with Crohn's disease who developed acute pancreatitis within two weeks of starting 6-MP. Discontinuation of the drug followed by fluid resuscitation led to the overall improvement of symptoms within 72 hours. No complications were noted during the follow-up. It is our intention to raise awareness for this lesser-known side effect with this case report and to urge physicians to provide thorough counseling prior to starting on this medication, especially in patients with inflammatory bowel disease (IBD). Additionally, we hope to reinforce this disease entity as a differential for acute pancreatitis and aim to emphasize the importance of detailed medication reconciliations with this report, especially in the emergency department, to enable quick diagnoses and limit unnecessary treatments.

摘要

作为维持克罗恩病缓解的一线免疫抑制剂,6-巯基嘌呤(6-MP)已被广泛使用。这种药物罕见、不可预测、与剂量无关的特异反应是急性胰腺炎。与该药物其他已得到充分描述且通常与剂量相关的副作用不同,急性胰腺炎是一种在临床实践中不常遇到的罕见不良反应。在本病例报告中,我们描述了一名40岁的克罗恩病男性患者,在开始使用6-MP两周内发生了急性胰腺炎。停药并进行液体复苏后,症状在72小时内总体得到改善。随访期间未发现并发症。我们希望通过本病例报告提高对这种鲜为人知的副作用的认识,并敦促医生在开始使用这种药物之前提供全面的咨询,尤其是对于炎症性肠病(IBD)患者。此外,我们希望强化将这种疾病实体作为急性胰腺炎的鉴别诊断,并旨在通过本报告强调详细药物核对的重要性,尤其是在急诊科,以便能够快速诊断并减少不必要的治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f1f/10060005/f91381f1ab56/cureus-0015-00000035554-i01.jpg

相似文献

1
Stomach Pain Upon Stomach Pain: Medication-Induced Pancreatitis.
Cureus. 2023 Feb 27;15(2):e35554. doi: 10.7759/cureus.35554. eCollection 2023 Feb.
2
Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease.
J Crohns Colitis. 2015 Aug;9(8):676-9. doi: 10.1093/ecco-jcc/jjv086. Epub 2015 May 12.
3
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
Cochrane Database Syst Rev. 2015 Oct 30;2015(10):CD000067. doi: 10.1002/14651858.CD000067.pub3.
5
Adalimumab for maintenance of remission in Crohn's disease.
Cochrane Database Syst Rev. 2020 May 16;5(5):CD012877. doi: 10.1002/14651858.CD012877.pub2.
6
Pancreatitis in inflammatory bowel diseases.
J Clin Gastroenterol. 2010 Apr;44(4):246-53. doi: 10.1097/MCG.0b013e3181cadbe1.
7
Nature and course of pancreatitis caused by 6-mercaptopurine in the treatment of inflammatory bowel disease.
Gastroenterology. 1986 Oct;91(4):982-6. doi: 10.1016/0016-5085(86)90703-1.
8
Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine.
Aliment Pharmacol Ther. 2003 Aug 15;18(4):401-8. doi: 10.1046/j.1365-2036.2003.01683.x.
9
Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease.
Scand J Gastroenterol Suppl. 1999;230:111-5. doi: 10.1080/003655299750025633.
10
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
Cochrane Database Syst Rev. 2013 Apr 30(4):CD000545. doi: 10.1002/14651858.CD000545.pub4.

本文引用的文献

1
Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn's disease: a systematic review.
Frontline Gastroenterol. 2020 Jun 11;12(5):423-436. doi: 10.1136/flgastro-2020-101405. eCollection 2021.
2
Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.
PLoS One. 2020 Apr 17;15(4):e0231883. doi: 10.1371/journal.pone.0231883. eCollection 2020.
4
Thiopurine-induced pancreatitis in inflammatory bowel diseases.
Expert Rev Gastroenterol Hepatol. 2015 Apr;9(4):399-403. doi: 10.1586/17474124.2015.992879. Epub 2014 Dec 15.
5
Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease.
Pediatr Gastroenterol Hepatol Nutr. 2012 Dec;15(4):272-5. doi: 10.5223/pghn.2012.15.4.272. Epub 2012 Dec 31.
6
Clinical pharmacology and pharmacogenetics of thiopurines.
Eur J Clin Pharmacol. 2008 Aug;64(8):753-67. doi: 10.1007/s00228-008-0478-6. Epub 2008 May 28.
7
Thiopurine metabolite monitoring in paediatric inflammatory bowel disease.
Aliment Pharmacol Ther. 2007 Apr 15;25(8):941-7. doi: 10.1111/j.1365-2036.2007.03278.x.
8
Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.
Aliment Pharmacol Ther. 2006 Jul 15;24(2):331-42. doi: 10.1111/j.1365-2036.2006.02977.x.
9
Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.
Clin Gastroenterol Hepatol. 2004 Sep;2(9):731-43. doi: 10.1016/s1542-3565(04)00344-1.
10
The pancreas and inflammatory bowel diseases.
Int J Pancreatol. 2000 Jun;27(3):171-9. doi: 10.1385/IJGC:27:3:171.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验